Sanne de Jongh
Sanne is an Analyst at Anterra Capital. She began her investing career at MS Ventures, the venture capital arm of Merck Serono, where she focussed on early stage investments in the pharmaceutical industry. During this time, she worked on deal sourcing and portfolio management.
Sanne holds a Masters in Biochemical Engineering from the Delft University of Technology. She has also studied at Leiden University and has conducted research in the fields of neurology, bionanoscience and environmental biotechnology.